Skip to content
healthcare.dev

Risedronate Sodium

NDC 65862-517, Risedronate Sodium, tablet, film coated, from Aurobindo Pharma Limited.

Product NDC
65862-517
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA200296
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65862-517 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RISEDRONATE SODIUM5 mg/1

Pharmacologic classes

Bisphosphonate [EPC]; Diphosphonates [CS]

Package NDCNDC-11Package
65862-517-22658620517222000 TABLET, FILM COATED in 1 BOTTLE (65862-517-22)
65862-517-306586205173030 TABLET, FILM COATED in 1 BOTTLE (65862-517-30)
65862-517-786586205177810 BLISTER PACK in 1 CARTON (65862-517-78) / 10 TABLET, FILM COATED in 1 BLISTER PACK (65862-517-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/89896dfe-f69d-4cb3-bb71-7a7c611071fa

Use it

Look up 65862-517 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65862-517 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65862-517. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.